Home > Products & Services > Regenerative System > Emdogain > Functional advantage

Print |  Forward page

True functional advantage with Straumann® Emdogain

Improved outcome and esthetics

Straumann® Emdogain regenerates periodontal tissue1 and significantly improves the outcome of surgical treatment alone:

  • Almost doubles the "highly improved"Clinical Attachment Level (CAL) gain (>4 mm) compared to open flap debridement (OFD) alone2
  • Tripled average percent of defect fill from 23% for surgical procedure alone to 74%3
  • Increases root coverage compared to coronally advanced flap (CAF) alone4,5 or connective tissue graft6

Long term effectiveness – sustained results

Straumann® Emdogain demonstrates long term clinical benefits:

  • Clinical success maintained over at least 9 years7
  • Continued improvement of clinical attachment level gain and recession reduction beyond 12 months was shown in a 5 year study8

Reduced complications – Improved satisfaction

Regenerative therapy with Straumann® Emdogain exhibits fewer complications than alternative methods:

  • Lower complication rate (dehiscences); 6% vs. almost 100% for guided tissue regeneration (GTR)9
  • Fewer patients with swelling; 56% vs. 94% for GTR10
  • Less patient pain; 38% had pain one-week post-op compared to 88% for GTR10 and 5% with pain vs. 45% when comparing CAF and CTG respectively6

Moreover, clinicians have reported enhanced wound healing through Straumann® Emdogain.6,11

1 Hamarström J Clin Periodontol 1997; 24; 658 and 669
2 Tonetti et al. J Clin Periodontology 2002; 29: 317-325
3 Froum, J Periodontol. 2001; 72: 25
4 Castellanos et al. J Periodontol. 2006; 77: 7-14
5 Cueva et al. J Periodontol. 2004; 75: 949-956
6 McGuire, Nunn, J Periodontol 2003; 74: 1110-1125
7 Sculean et al. Int J Periodontics Restorative Dent. 2007; 27: 221
8 Heden et al. J Periodontol 2006; 77: 295-301
9 Sanz et al J. Periodontol, 2004, 726-733
10 Jepsen, Meyle et al. J Periodontol. 2004; 75: 1150
11 Wennstrom et al J Clin Periodontol. 2002, 29: 9-14